Leukemia Information

Return to Previous Page

Diagnosis: CLL

Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lympho­cytes (a type of white blood cell). CLL, a slow-growing blood and bone marrow disease, is one of the most common types of leukemia in adults.

Read More


How Is Chronic Myeloid Leukemia Treated?

Treatment options and recommen­dations for people with chronic myeloid leukemia depend on several factors, including the phase of the disease, possible side effects, and your preferences and overall health. Take time to learn about your treatment options, and be sure to ask questions about things that are unclear. Also, dis­cuss the goals of each treatment with your doctor and ask what you can expect while receiving the treatment.

Read More


FDA Approves Gazyva for Chronic Lymphocytic Leukemia

The U.S. Food and Drug Administration has approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL). Gazyva works by helping certain cells in the immune system attack cancer cells. Gazyva is intended to be used with chlorambucil, another drug used to treat patients with CLL.

Read More


Treating Chronic Myelogenous Leukemia

Different types of treat­ment are available for people with chronic myelogenous leukemia (CML). Some treatments are standard (the currently used treat­ment), and some are being tested in clinical trials. The six types of standard treatment used to treat CML are tar­geted therapy, chemotherapy, biologic therapy, high-dose chemotherapy with stem cell transplant, donor lymphocyte infusion, and surgery.

Read More


FDA Approves Iclusig to Treat Two Rare Types of Leukemia

The U.S. Food and Drug Administration has approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases. Iclusig is being approved more than three months ahead of the product’s prescription user fee goal date.

Read More


Realistic Optimism in Cancerville

by William Penzer, PhD

Not knowing what will happen brings out the frightened, con­fused, and overwhelmed parts of us in all life’s areas, and especially in Cancerville. The philosophy of realis­tic optimism seeks to offset our automatic pessimistic reactions. It strives to replace hopelessness with hopefulness, within realistic boundaries.

Read More


What Happens Once CML Treatment Begins?

To assess your response to treatment for chronic myelogenous leukemia, you will need to undergo blood and marrow tests before and during treatment. These tests include complete blood count (CBC), cytogenetic analysis, and quantitative polymerase chain reaction (QPCR). How often you will need these tests depends on the time since your treatment started and your previous test results. There are three different types of response to medications.

Read More


Living with CML

If you’ve been diagnosed with chronic myelogenous leukemia, you may need help with practical tasks, such as sorting through treatment information, managing side effects, and finding financial help for medical expenses. Your healthcare team, which can include your doctor, CML specialist, nurse, social worker, and others, can assist you in many of these areas. Here are some steps you can take to find the support you need.

Read More


Page 1 of 3  1 2 3 > 


eUpdate Sign up

Receive e-mails with links to the latest content on the Coping with Cancer website.

See past issues of eUpdate.

Follow us on Twitter

          Twitter icon

Like us on Facebook

          FaceBook icon

Subscribe to
Coping with Cancer magazine